Ashfords advised Craven Street Wealth on the deal. Craven Street Wealth proposed the acquisition of Punter Southall Aspire’s financial planning division. The deal, due to be...
Craven Street Wealth’s Acquisition of Punter Southall Aspire’s Financial Planning Division
Vamstar’s $9.5 Million Series A Funding Round
Ashfords advised Vamstar on the deal. Vamstar executed a $9.5 million Series A funding round, led by Korean investors Mirae Asset and Celltrion. Vamstar is a leading AI-based...
Nesta’s £15.4 Million Acquisition of Behavioural Insights
Ashfords acted for management on the deal. Behavioural Insights, a company which uses behavioural science to devise low or no-cost interventions that change public behaviour for...
Iksuda Therapeutics’ £29.6 Million Series A Financing Round
Ashfords advised life sciences company Iksuda Therapeutics on the deal. Bird & Bird advised Mirae Asset Capital, Celltrion and Premier Partners. Iksuda is the developer of...
Iksuda Therapeutics’ £29.6 Million Series A Financing Round
Ashfords advised life sciences company Iksuda Therapeutics on the deal. Bird & Bird advised Mirae Asset Capital, Celltrion and Premier Partners. Iksuda is the developer of...
Craven Street Capital’s Acquisition Of Kreston Reeves Financial Planning
Ashfords LLP has advised Craven Street Capital on the deal. Craven Street Capital acquired Kreston Reeves Financial Planning (KRFP), establishing Craven Street Wealth. Based in London, Craven...